newsfilter
← Latest News
GlobeNewswire·

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnoutsVivasure Medical Limited ("Vivasure") has been a strategic holding of Orchestra